» Articles » PMID: 15811177

Inactivation of MAP Kinase Signalling in Myc Transformed Cells and Rescue by LiCl Inhibition of GSK3

Overview
Journal Mol Cancer
Publisher Biomed Central
Date 2005 Apr 7
PMID 15811177
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

c-Myc oncogene is an important regulator of cell cycle and apoptosis, and its dysregulated expression is associated with many malignancies. Myc is instrumental in directly or indirectly regulating the progression through the G1 phase and G1/S transition, and transformation by Myc results in perturbed cell cycle. Also contributory to the control of G1 is the Ras effector pathway Raf/MEK/ERK MAP kinase. Together with GSK3, ERK plays an important role in the critical hierarchical phosphorylation of S62/T58 controlling Myc protein levels. Therefore, our main aim was to examine the levels of MAPK in Myc transformed cells in light of the roles of ERK in cell cycle and control of Myc protein levels. We found that active forms of ERK were barely detectable in v-Myc (MC29) transformed cells. Furthermore, we could only detect reduced levels of activated ERK in c-Myc transformed cells compared to the non-transformed primary chick embryo fibroblast cells. The addition of LiCl inhibited GSK3 and successfully restored the levels of ERK in v-Myc and c-Myc transformed cells to those found in non-transformed cells. In addition, LiCl stabilised Myc protein in the non-transformed and c-Myc transformed cells but not in v-Myc transformed cells. These results can provide an important insight into the role of MAPK in the mechanism of Myc induced transformation and carcinogenesis.

Citing Articles

Metallic nickel nanoparticles may exhibit higher carcinogenic potential than fine particles in JB6 cells.

Magaye R, Zhou Q, Bowman L, Zou B, Mao G, Xu J PLoS One. 2014; 9(4):e92418.

PMID: 24691273 PMC: 3972196. DOI: 10.1371/journal.pone.0092418.


Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta.

Yun S, Yoon H, Jeong S, Chung Y J Bone Miner Metab. 2008; 27(2):140-8.

PMID: 19066717 DOI: 10.1007/s00774-008-0019-5.


Retraction: Inactivation of MAP kinase signalling in Myc transformed cells and rescue by LiCl inhibition of GSK3.

Al-Assar O, Crouch D Mol Cancer. 2005; 4(1):17.

PMID: 15877819 PMC: 1097756. DOI: 10.1186/1476-4598-4-17.

References
1.
Watson J, Oster S, Shago M, Khosravi F, Penn L . Identifying genes regulated in a Myc-dependent manner. J Biol Chem. 2002; 277(40):36921-30. DOI: 10.1074/jbc.M201493200. View

2.
Black E, Walker M, Clark W, MacLaren A, Gillespie D . Cell transformation by v-Jun deactivates ERK MAP kinase signalling. Oncogene. 2002; 21(42):6540-8. DOI: 10.1038/sj.onc.1205851. View

3.
Menssen A, Hermeking H . Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A. 2002; 99(9):6274-9. PMC: 122939. DOI: 10.1073/pnas.082005599. View

4.
Self A, Caron E, PATERSON H, Hall A . Analysis of R-Ras signalling pathways. J Cell Sci. 2001; 114(Pt 7):1357-66. DOI: 10.1242/jcs.114.7.1357. View

5.
Morgan M, Dolp O, Reuter C . Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling. Blood. 2001; 97(6):1823-34. DOI: 10.1182/blood.v97.6.1823. View